The Psychedelic Practitioner Issue 7: Preparedness and the Systems Needed to Deliver Psychedelic Therapies

This issue examines how clinicians, practices, health systems and clinic networks can prepare to deliver psychedelic therapies, particularly in anticipation of possible U.S. FDA approvals. The focus is on operational systems rather than individual training, including treatment space, staffing, screening, preparation and integration, REMS compliance, medicine supply, documentation, outcomes measurement, reimbursement and equitable access. Interviews with practitioners in the U.S., Australia and Oregon emphasize starting small, building supervision and administrative capacity, collecting structured real-world evidence, and designing workflows before treating the first patient. Contributors also warn that several-hour sessions, limited room and clinician capacity, complex patient populations, transportation and time demands, and uncertain insurance coverage could restrict access. The issue includes updates on FDA engagement, MDMA and psilocybin applications, Compass Pathways' possible launch plans, and an LSD candidate in development.